FDA Takes “Property”-Based Approach To Nanotech, Raises Roof To 1 Micron
This article was originally published in The Rose Sheet
Executive Summary
In its newly released guidance to industry, FDA indicates that “agglomerates and aggregates” of materials that exceed the oft-cited ceiling of 100 nanometers may still warrant consideration as nanotechnology based on their “properties,” a position that could impact the cosmetics sector.